Home › Atopic Dermatitis (Eczema) › Ohio
Atopic Dermatitis (Eczema) clinical trials in Ohio
10 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Ohio.
Cities in Ohio
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
RecruitingObservational study
Ages 12 and older · All sexes · Updated Sep 29, 2026 · NCT07290803A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Apex Clinical Research Center, LLC., Mayfield Heights
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 25, 2026 · NCT07216027Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Canton
- Enveda Investigative Site, Mayfield Heights
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Boardman
- Investigational Site, Mason
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ClinOhio Research Services, Columbus
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
- Wright State Physicians Health Center /ID# 268841, Fairborn
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Aug 6, 2026 · NCT06461897Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
RecruitingPhase 1
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Apex Clinical Research Center, Mayfield Heights
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7081, Dayton
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.